FDA Warns Matrixx On Combination Supplement/Drug Products
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.